Restart of Anticoagulant Therapy and Risk of Thrombosis, Rebleeding, and Death after Factor Xa Inhibitor Reversal in Major Bleeding Patients

Background  Lack of data on balancing bleeding and thrombosis risk causes uncertainty about restarting anticoagulants after major bleeding. Anticoagulant reversal trials offer prospectively gathered data after major bleeding with well-documented safety events and restarting behavior. Objectives  To...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thromb Haemost
Main Authors: Milling, Truman J., King, Ben, Yue, Patrick, Middeldorp, Saskia, Beyer-Westendorf, Jan, Eikelboom, John W., Crowther, Mark, Xu, Lizhen, Verhamme, Peter, Siegal, Deborah M., Connolly, Stuart J.
Formato: Artigo
Idioma:Inglês
Publicado em: Georg Thieme Verlag KG 2021
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8322590/
https://ncbi.nlm.nih.gov/pubmed/33634446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/a-1400-6159
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados